Brellium Appoints Former Medicaid CMO Dr. Andrey Ostrovsky as Strategic Advisor

Brellium Strengthens Compliance Strategy With Addition of Former Medicaid Chief Medical Officer Dr. Andrey Ostrovsky

Brellium, a healthcare compliance platform used by more than 200 healthcare organizations across the United States, has announced the appointment of Dr. Andrey Ostrovsky, MD, as a strategic advisor. The move reflects the company’s continued focus on helping providers and payers navigate an increasingly complex healthcare regulatory environment while improving transparency and operational efficiency across the healthcare ecosystem.

Dr. Ostrovsky brings decades of experience spanning federal healthcare policy, Medicaid leadership, clinical care, and healthcare investment. His appointment is expected to strengthen Brellium’s position as the company works to build a compliance infrastructure that can serve as a trusted source of truth for both providers and payers.

Brellium’s leadership believes the addition of Dr. Ostrovsky comes at a critical moment for the healthcare industry. Providers across the country are facing heightened audit activity, stricter documentation requirements, and changing reimbursement rules, while payers continue adapting to evolving Medicaid policies, risk management pressures, and increasing oversight from the Centers for Medicare & Medicaid Services (CMS).

The company’s platform is designed to simplify compliance workflows, reduce administrative burdens, and improve alignment between healthcare organizations and insurance payers. By integrating automation and standardized compliance processes, Brellium aims to reduce friction that often leads to denied claims, billing disputes, and operational inefficiencies.

Dr. Ostrovsky currently serves as managing partner at Social Innovation Ventures, where he advises and invests in organizations focused on improving healthcare access, advancing healthcare delivery, and reducing disparities in care. Over the years, he has earned recognition for his work at the intersection of policy, innovation, and patient-centered healthcare reform.

Prior to his role at Social Innovation Ventures, Dr. Ostrovsky served as chief medical officer for the Center for Medicaid and CHIP Services, a division within CMS. During his tenure under both the Obama administration and the first Trump administration, he helped oversee the nation’s largest health insurance system, which provides healthcare coverage to nearly 90 million Americans through Medicaid and the Children’s Health Insurance Program (CHIP).

In that role, he played a major part in shaping Medicaid payment policy and advising on healthcare delivery reforms aimed at improving patient outcomes while controlling costs. Colleagues and healthcare leaders widely viewed him as someone capable of balancing operational efficiency with patient protections — an approach that earned respect from both policymakers and healthcare providers.

Brellium executives believe this unique background makes Dr. Ostrovsky especially valuable as the company expands its work with healthcare organizations nationwide.

“Dr. Ostrovsky understands the healthcare system from every angle,” said Zach Rosen, CEO of Brellium. “He has worked at the highest levels of federal healthcare policy while also understanding the day-to-day realities providers face. That perspective will help us continue building solutions that improve compliance while supporting better patient care.”

According to Rosen, the healthcare industry continues to struggle with fragmented compliance systems and inconsistent documentation standards. These issues often create tension between providers and payers, slowing reimbursements and increasing administrative costs.

“Healthcare organizations spend enormous amounts of time and resources trying to interpret changing regulations and documentation requirements,” Rosen added. “Our goal is to reduce that complexity and create alignment between all stakeholders involved in healthcare delivery.”

Brellium’s platform focuses on helping organizations identify compliance gaps, automate documentation review processes, and improve audit readiness. The company says its technology enables providers and payers to operate with greater transparency while reducing uncertainty surrounding billing and care authorization.

Dr. Ostrovsky’s appointment comes during a period of intensified scrutiny across the healthcare sector. Federal agencies have increased enforcement activity tied to Medicaid billing practices, documentation accuracy, and quality reporting standards. At the same time, many healthcare providers are struggling with staffing shortages, financial pressures, and rising administrative workloads.

Healthcare experts note that these pressures have made compliance management more important than ever. Even minor documentation errors can lead to delayed payments, denied claims, or costly penalties. As regulations continue evolving, healthcare organizations are searching for tools that can simplify compliance operations without compromising patient care.

Dr. Ostrovsky said he believes Brellium’s mission aligns closely with the broader need for healthcare system modernization.

“Documentation complexity and ambiguity continue to create barriers for providers and patients alike,” he said. “When compliance systems become overly burdensome, they distract from what matters most — delivering quality patient care.”

He emphasized that improving communication and alignment between payers and providers can help reduce unnecessary disputes while improving patient experiences.

“Providers want confidence that the care they deliver will be appropriately authorized and reimbursed,” Dr. Ostrovsky explained. “Patients want to avoid unexpected denials or interruptions in care. Creating a shared understanding around quality and compliance is critical to achieving those goals.”

Beyond his federal healthcare leadership experience, Dr. Ostrovsky also brings firsthand operational experience as a clinician and healthcare operator. He has worked directly with addiction treatment organizations and operated methadone clinics, giving him direct insight into the compliance and administrative challenges faced by providers on the front lines of patient care.

This combination of policy expertise and clinical experience is expected to help Brellium strengthen its product development strategy and deepen relationships with healthcare organizations navigating increasingly complex regulatory demands.

Industry observers say healthcare compliance technology is becoming one of the fastest-growing segments within healthcare IT, driven by expanding regulatory requirements and the need for operational efficiency. Companies like Brellium are working to modernize systems that have historically relied heavily on manual reviews and fragmented documentation practices.

As healthcare systems continue shifting toward value-based care models, accurate documentation and compliance monitoring are becoming even more important. Payers and providers must increasingly demonstrate quality outcomes, maintain audit readiness, and ensure that reimbursement practices align with evolving federal and state regulations.

Brellium believes its platform can play a central role in helping organizations adapt to these changes. By automating key compliance functions and improving visibility into documentation standards, the company aims to reduce administrative friction while strengthening trust between healthcare stakeholders.

The addition of Dr. Ostrovsky signals Brellium’s intention to expand its influence within the healthcare compliance landscape and deepen its engagement with both public and private healthcare organizations.

As the healthcare industry continues to evolve, leaders across the sector are recognizing the importance of balancing regulatory oversight with operational simplicity. Companies that can help streamline compliance while improving collaboration between payers and providers are expected to play an increasingly important role in shaping the future of healthcare delivery.

With Dr. Ostrovsky joining as strategic advisor, Brellium is positioning itself to accelerate its efforts in creating a more transparent, efficient, and patient-centered compliance system for the modern healthcare environment.

About Brellium

 Brellium is the compliance and quality platform for healthcare, analyzing every patient visit for quality, accuracy, and risk — helping provider groups stay compliant, reduce risk exposure, and deliver better patient outcomes.

Source Link